Literature DB >> 32570800

Cholesterol and Alzheimer's Disease Risk: A Meta-Meta-Analysis.

Olalla Sáiz-Vazquez1, Alicia Puente-Martínez2, Silvia Ubillos-Landa3, Joaquín Pacheco-Bonrostro4, Javier Santabárbara5,6.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is the most common subtype of dementia. In the last ten years, the relationship between cholesterol and AD has been investigated. Evidence suggests that cholesterol is associated with AD and represents promising targets for intervention. However, the causality of these associations is unclear. Therefore, we sought to conduct a meta-meta-analysis to determine the effect of cholesterol on the development AD. Then, we assessed the effect of serum levels of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC) and triglycerides (TG), on AD risk.
METHODS: A systematic search of meta-analyses was conducted. Scopus, Web of Science, Science direct, PubMed and Google academic system databases were reviewed.
RESULTS: We found 100 primary studies and five meta-analyses to analyze the relationships between cholesterol and AD. The total effect of cholesterol on risk of AD was significant and heterogeneous. Subgroup analysis shows that LDL-C levels influence the development of AD. However, non-significant effects of HDL-C, TC and TG levels on AD were found.
CONCLUSIONS: These results strengthen the evidence that LDL-C cholesterol levels increase risk for AD. More initiatives to investigate the relationship between cholesterol and AD are needed.

Entities:  

Keywords:  Alzheimer’s disease; cholesterol; etiology; meta-analysis; risk factors

Year:  2020        PMID: 32570800     DOI: 10.3390/brainsci10060386

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  15 in total

1.  Sex differences in the association between major cardiovascular risk factors in midlife and dementia: a cohort study using data from the UK Biobank.

Authors:  Jessica Gong; Katie Harris; Sanne A E Peters; Mark Woodward
Journal:  BMC Med       Date:  2021-05-19       Impact factor: 11.150

2.  Depression as a Risk Factor for Dementia and Alzheimer's Disease.

Authors:  Vanesa Cantón-Habas; Manuel Rich-Ruiz; Manuel Romero-Saldaña; Maria Del Pilar Carrera-González
Journal:  Biomedicines       Date:  2020-10-28

3.  Association between ApoE ε4 Carrier Status and Cardiovascular Risk Factors on Mild Cognitive Impairment among Mexican Older Adults.

Authors:  Sara G Aguilar-Navarro; Itzel I Gonzalez-Aparicio; José Alberto Avila-Funes; Teresa Juárez-Cedillo; Teresa Tusié-Luna; Alberto Jose Mimenza-Alvarado
Journal:  Brain Sci       Date:  2021-01-07

4.  Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Vasiliki Efthymiou; George P Chrousos
Journal:  BMC Med       Date:  2021-01-13       Impact factor: 8.775

Review 5.  Synapses, Microglia, and Lipids in Alzheimer's Disease.

Authors:  Patrick J Paasila; Jason A Aramideh; Greg T Sutherland; Manuel B Graeber
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

6.  Apolipoprotein E Induced Cognitive Dysfunction: Mediation Analysis of Lipids and Glucose Biomarkers in an Elderly Cohort Study.

Authors:  Linxin Liu; Huichu Li; Hari Iyer; Andy J Liu; Yi Zeng; John S Ji
Journal:  Front Aging Neurosci       Date:  2021-08-13       Impact factor: 5.750

7.  Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.

Authors:  Jamie A Browning; Chi Chun Steve Tsang; Xiaobei Dong; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Colin Liu; Junling Wang
Journal:  BMC Health Serv Res       Date:  2022-02-07       Impact factor: 2.655

8.  Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells.

Authors:  Daniel Janitschke; Anna Andrea Lauer; Cornel Manuel Bachmann; Jakob Winkler; Lea Victoria Griebsch; Sabrina Melanie Pilz; Elena Leoni Theiss; Heike Sabine Grimm; Tobias Hartmann; Marcus Otto Walter Grimm
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

Review 9.  Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes?

Authors:  Erica Staurenghi; Serena Giannelli; Gabriella Testa; Barbara Sottero; Gabriella Leonarduzzi; Paola Gamba
Journal:  Antioxidants (Basel)       Date:  2021-11-26

10.  Alzheimer's Disease and Oral-Systemic Health: Bidirectional Care Integration Improving Outcomes.

Authors:  Anne O Rice
Journal:  Front Oral Health       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.